Search for: "NOVARTIS CORPORATION"
Results 21 - 40
of 314
Sorted by Relevance
|
Sort by Date
19 Nov 2011, 5:55 am
These findings send a clear message to all other large corporations in America that gender discrimination will not be tolerated in the workplace. [read post]
23 Apr 2022, 8:47 pm
Brett Alten of Hewlett Packard Enterprise; Bowman Heiden of the Tusher Center for the Management of Intellectual Capital, UC-Berkeley; Allen Lo of Meta Platforms: and Corey Salsberg of Novartis will discuss the origin of corporate pledges regarding lowering carbon footprints, increasing diversity within organizations, and sharing IP in the fight against COVID, how these pledges can impact organizations, and whether they work. [read post]
13 Aug 2020, 7:34 am
In a settlement in a separate case, announced on July 1, Novartis Pharmaceutical Corporation agreed to pay $642 million to settle a False Claims Act case. [read post]
13 Jul 2020, 12:59 pm
On July 1, Novartis Pharmaceuticals Corporation agreed to pay $642 million to settle a False Claims Act case brought by a whistleblower. [read post]
26 Jul 2010, 11:36 am
This mirrors a similar decision we discussed in April of 2009 against Schering Corporation. [read post]
12 Mar 2014, 12:43 pm
Novartis Pharmaceuticals Corporation, et al. v. [read post]
17 Jan 2018, 1:16 pm
Novartis Pharmaceuticals Corporation, S233898).Prévisibilité du dommage en responsabilité civile et contractuelle (droit californien) :Face à la question de savoir si un défendeur répond envers un lésé, le droit californien accorde une importance essentielle à la notion de prévisibilité. [read post]
14 Feb 2012, 1:45 pm
We believe in holding corporations accountable for conduct that puts our families and yours at risk every single day --and all in the name of profits. [read post]
14 Feb 2012, 1:45 pm
We believe in holding corporations accountable for conduct that puts our families and yours at risk every single day --and all in the name of profits. [read post]
14 Jan 2018, 6:34 am
Novartis Pharmaceuticals Corporation, S233898).Exigences en matière d'étiquetages et notices, ici de médicaments et de dispositifs médicaux Le droit des états, ici californien, protège substantiellement les consommateurs de médicaments des dangers posés par des étiquetages et des notices faux, trompeurs ou inadéquats. [read post]
19 Jul 2022, 7:46 am
., vacated its prior decision, and reversed the district court’s judgment that the claims of patent at issue were not invalid (Novartis Pharmaceuticals Corporation. v. [read post]
8 Jun 2010, 1:58 pm
Altogether, around 5,600 women may receive compensation from the corporation. [read post]
4 May 2010, 10:29 pm
According to DOJ’s press release: Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation have agreed to pay $72.5 million to resolve civil False Claims Act allegations arising from the marketing of the cystic fibrosis drug TOBI, the Justice Department announced today. [read post]
3 Jun 2010, 2:54 pm
Fostering diversity programs within the workplace are good business and help to create a good corporate image while recruiting minority applicants. [read post]
17 Jan 2018, 1:25 pm
Novartis Pharmaceuticals Corporation, S233898).Le devoir de diligence est une des conditions centrales de l'obligation de réparer un dommage en responsabilité civile. [read post]
5 Oct 2022, 6:51 am
A Corporation’s legal location has been in-flux for a number of years with several Supreme Court cases narrowing the scope to basically the corporation’s state of registration. [read post]
13 Jan 2018, 8:00 pm
Novartis suggests that we recently conflated strict liability and negligence in Webb v. [read post]
8 May 2012, 6:42 am
Pharmaceuticals corporation Novartis has recently settled a class action lawsuit brought by current and former sales representatives for $99 million dollars. [read post]
16 Sep 2016, 4:07 am
John Collins and Sumer DayalClayton Utz On 9 September 2016, the Full Federal Court of Australia delivered its judgment in Actavis Pty Ltd v Orion Corporation [2016] FCAFC 121 (Actavis). [read post]
3 Apr 2007, 2:55 pm
Novartis Suspends Sales After FDA Determines That Risks Of Serious Side Effects Outweigh Benefits Of Zelnorm (Posted by Tom Lamb at DrugInjuryWatch.com) On March 30, 2007 the FDA announced that Novartis Pharmaceuticals Corporation had suspended the marketing and sales of Zelnorm (tegaserod), a widely prescribed medication for irritable bowel syndrome (IBS) and constipation, due to an apparent increased risk of heart attacks and strokes in patients using Zelnorm. [read post]
